Lipigon Pharmaceuticals
0,125
SEK
0 %
LPGO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Mindre end 1K følgere
0%
+8,15%
-35,67%
-39,86%
-63,19%
-75,04%
-97,17%
-
-98,31%
Lipigon Pharmaceuticals operates in the pharmaceutical industry. The company specializes in the research and development of various drug candidates. The product portfolio is broad and includes drugs for rare diseases. These are mainly treatments for diseases caused by disorders in the body's handling of fats. In addition to the main business, service and associated ancillary services are also offered. Lipigon Pharmaceuticals operates worldwide, with the largest presence in the Nordic market.
Læs mereMarkedsværdi
18,51 mio. SEK
Aktieomsætning
15,07 t SEK
Omsætning
16,41 mio.
EBIT %
-75,38 %
P/E
-
Udbytteafkast, %
-
Finanskalender
19.2
2025
Årsrapport '24
27.5
2025
Delårsrapport Q1'25
26.8
2025
Delårsrapport Q2'25
ViserAlle indholdstyper
Första patienten doserad i Lipigon Pharmaceuticals kliniska fas II-studie med Lipisense®
Lipigon's development partner Leaderna Therapeutics reports last person treated in ongoing Phase 1 study with Lipisense®
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools